Y
Yuping Li
Researcher at First Affiliated Hospital of Wenzhou Medical University
Publications - 29
Citations - 198
Yuping Li is an academic researcher from First Affiliated Hospital of Wenzhou Medical University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 6, co-authored 17 publications receiving 99 citations.
Papers
More filters
Journal ArticleDOI
STAT1 modification improves therapeutic effects of interferons on lung cancer cells
Junjie Chen,Jialu Zhao,Lefu Chen,Nian Dong,Zhaojian Ying,Zhenzhen Cai,Dongxiang Ji,Yong Zhang,Dong Li,Yuping Li,Lei Jiang,Michael J. Holtzman,Chengshui Chen +12 more
TL;DR: Results from this study suggest that combined treatment of IFNs and STAT1-CC might be a feasible approach for the clinical management of lung cancer in the future.
Journal ArticleDOI
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study.
Yuankai Shi,Gongyan Chen,Xinkang Wang,Yunpeng Liu,Lin Wu,Yanrong Hao,Chunling Liu,Shuyang Zhu,Xiaodong Zhang,Yuping Li,Jiwei Liu,Lejie Cao,Ying Cheng,Hui-fang Zhao,Shucai Zhang,Aimin Zang,Jiuwei Cui,Jian Feng,Nong Yang,Fei Liu,Yong Jiang,Chuan Gu +21 more
TL;DR: Furmonertinib (AST2818) is an irreversible, selective, third-generation EGFR tyrosine-kinase inhibitor as discussed by the authors , which is a new potential treatment option for this population.
Journal ArticleDOI
Primary intravascular large B-cell lymphoma of the lung: a review and case report
TL;DR: Primary pulmonary IVLBCL of the lung is extremely rare, on chest CT it manifests as diffuse ground glass shadow, or nodular consolidations in the lung, lactate dehydrogenase and C-reactive protein was found to increase, fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is an important and significant diagnostic modality in its early diagnosis.
Journal ArticleDOI
Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
TL;DR: This is the first case report of small cell transformation and metastatic to the breast in a patient with lung adenocarcinoma following EGFR-TKI treatment.
Journal ArticleDOI
Detection of plasma T790M mutation after the first generation EGFR-TKI resistance of non-small cell lung cancer in the real world.
Haiyan Li,Jinwei Wang,Guojing Zhang,Yuping Li,Ling Lin,Haihua Yang,Jingjing Zhou,Lingna Zhang,Dongqing Lv +8 more
TL;DR: The positive rate of T790M mutation after the failure of firstgeneration EGFR-TKI treatment was not correlated with the patient's age, sex, and the type of first generation TKI drugs, however, it was related to the mutation type of EGFR in baseline and the mode of progression.